Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Tandem Diabetes Care (TNDM)

Tandem Diabetes Care (TNDM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Tandem Diabetes Care 12400 HIGH BLUFF DRIVE San Diego CA 92130 USA

www.tandemdiabetes.com P: 858-366-6900 F: 858-362-7070

Description:

Tandem Diabetes Care, Inc. designs, develops and markets products for people with insulin-dependent diabetes. The company's flagship product, the t:slim X2 Insulin Delivery System, or t:slim X2, is based on its proprietary technology platform. Per the company, t:slim X2 is the smallest durable insulin pump available and is also the only available pump capable of remote feature updates.Tandem Diabetes also offers t:flex insulin delivery system which includes t:flex pump, its 480-unit disposable insulin cartridge, an infusion set, t:lock cartridge and infusion set products, various pump accessories along with t:slim X2 with G5 integration.

Key Statistics

Overview:

Market Capitalization, $K 2,267,453
Enterprise Value, $K 2,208,583
Shares Outstanding, K 64,563
Annual Sales, $ 747,720 K
Annual Net Income, $ -222,610 K
Last Quarter Sales, $ 196,800 K
Last Quarter Net Income, $ -30,000 K
EBIT, $ -233,240 K
EBITDA, $ -211,730 K
60-Month Beta 1.12
% of Insider Shareholders 2.50%
Float, K 62,949
% Float 97.50%
Short Volume Ratio 0.71

Growth:

1-Year Return -2.12%
3-Year Return -61.31%
5-Year Return -47.21%
5-Year Revenue Growth 306.66%
5-Year Earnings Growth 38.43%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.27 on 02/21/24
Latest Earnings Date 05/02/24 [AMC]
Earnings Per Share ttm -1.58
EPS Growth vs. Prev Qtr 28.95%
EPS Growth vs. Prev Year -2,600.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 10/10/17

TNDM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -31.48%
Return-on-Assets % -10.75%
Profit Margin % -29.77%
Debt/Equity 0.00
Price/Sales 3.02
Price/Cash Flow N/A
Price/Book 6.60
Book Value/Share 4.81
Interest Coverage -21.29
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar